The seven-fold rise in incidence of Stevens-Johnson syndrome & toxic epidermal necrolysis: Associations with COVID-19 and the vaccine
- PMID: 37730480
- DOI: 10.1016/j.burns.2023.06.016
The seven-fold rise in incidence of Stevens-Johnson syndrome & toxic epidermal necrolysis: Associations with COVID-19 and the vaccine
Abstract
Stevens-Johnson syndrome (SJS)/toxic epidermal necrolysis (TEN) is a rare, potentially life threatening mucocutaneous hypersensitivity reaction resulting in desquamation of the skin and mucosa. These patients are managed on burns units due to the widespread desquamation. We report the largest case series of participants developing SJS/TEN in the setting of recent COVID infection or vaccination. We found a seven-fold increase in SJS/TEN since the COVID pandemic. This increase correlates with an increase in COVID infections and vaccination rates. We explore the immunopathological relationships between COVID and SJS/TEN and propose theories for possible associations.
Keywords: COVID-19; Stevens-Johnson syndrome; Toxic epidermal necrolysis.
Copyright © 2023. Published by Elsevier Ltd.
Conflict of interest statement
Declaration of Competing Interest None of the authors have any conflicts of interest to declare.
Comment in
-
COVID-19 vaccine and incidence of Stevens-Johnson syndrome & toxic epidermal necrolysis.Burns. 2023 Nov;49(7):1778-1779. doi: 10.1016/j.burns.2023.08.004. Epub 2023 Aug 11. Burns. 2023. PMID: 37833148 No abstract available.
-
Contextualising associations of SJS/TEN with COVID-19 and the vaccine.Burns. 2023 Nov;49(7):1776-1777. doi: 10.1016/j.burns.2023.08.003. Epub 2023 Aug 11. Burns. 2023. PMID: 37833150 No abstract available.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical